Skip to main content
. 2010 Jun 24;101(10):2093–2104. doi: 10.1111/j.1349-7006.2010.01654.x

Table 1.

Aberrations of Wiskott–Aldrich syndrome proteins (WASPs) and WASP family verprolin‐homologous proteins (WAVEs) in cancers

Gene Aberration Evidence Correlation Refs
WASPs
WASP Unknown
N‐WASP Up (colon) MA, RT Met [s1]
Up (esophagus) MA ND [s2]
Down (breast) RT, WB, IHC Met, bad prognosis [s3]
WIPs
WIPF1/2/3 Unknown
WAVEs
WAVE1 Up (prostate) RT, IHC Inv [s4]
Up (leukemia) RT, WB Resistance to apoptosis [s5]
WAVE2 Up (melanoma) WB Inv, met (12)
Up (breast) RT, IHC Inv, bad prognosis [s6, s7]
Up (lung)† IHC Bad prognosis [s8]
Up (colon)† IHC Met [s9]
WAVE3 TL (ganglioneuroblastoma) MA, RT Tumorigenesis [s10]
Up (breast) MA, RT, IHC Inv (99, 100)
Up (prostate) RT Inv [s11]
ABIs
Abi1 Up (breast) WB Inv [s12]
Down (stomach) IHC Met, bad prognosis [s7]
Abi2 Unknown
Abi3 Down (glioma) WB Met [s13]
HSPC300
HSPC300 Del (VHL kidney) MAP Suppression of tumorigenesis [s14–s16]
Up (lung) IHC Met [s17]
CYFIPs
CYFIP1 Down (breast, colon, etc.) IHC, RT Inv (95)
CYFIP2 Unknown
NckAPs
NckAP1/2 Unknown

References prefixed with “s” are provided as Supplementary Information. Abi, Abl‐interactor; Del, genomic deletion of HSPC300 accompanied by genetic loss of von Hippel‐Lindau (VHL) tumor suppressor. Loss of function of VHL gene is responsible for familial or sporadic VHL tumor syndrome; CYFIP, cytoplasmic FMR1 interacting protein 2; Down, gene product downregulated as indicated cancer advances; HSPC300, hematopoietic stem/progenitor cell protein 300; IHC, immunohistochemistry; Inv, invasion; MA, microarray; MAP, deletion mapping of chromosomes; Met, metastasis; NckAP, Nck‐associated protein; ND, not determined; N‐WASP, WASP homologue; RT, RT‐PCR; TL, genomic translocation found at the locus of the indicated gene; Up, gene product upregulated as indicated cancer advances; WB, Western blotting. —, not applicable; WIP, WASP‐interacting protein. †WAVE2 upregulation is seen with actin‐related protein 2 coexpression.